

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phasic smooth muscle contraction (GO:0014821) | 6.49047303 |
| 2 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 5.84632637 |
| 3 | regulation of cellular amino acid metabolic process (GO:0006521) | 5.69370937 |
| 4 | * cranial nerve structural organization (GO:0021604) | 5.65510680 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.63907932 |
| 6 | cellular response to estradiol stimulus (GO:0071392) | 5.46245725 |
| 7 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 5.39887235 |
| 8 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 5.36035273 |
| 9 | base-excision repair, AP site formation (GO:0006285) | 5.31921543 |
| 10 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 5.26189405 |
| 11 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 5.26189405 |
| 12 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 5.22395186 |
| 13 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 5.22395186 |
| 14 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 5.22395186 |
| 15 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 5.16839887 |
| 16 | negative regulation of ligase activity (GO:0051352) | 5.16839887 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 5.15592611 |
| 18 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 5.00668863 |
| 19 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 5.00633429 |
| 20 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 5.00633429 |
| 21 | regulation of timing of cell differentiation (GO:0048505) | 4.99868977 |
| 22 | regulation of development, heterochronic (GO:0040034) | 4.97474964 |
| 23 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.95379438 |
| 24 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.94021240 |
| 25 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.85891793 |
| 26 | proteasome assembly (GO:0043248) | 4.80919688 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.72798744 |
| 28 | positive regulation of hair follicle development (GO:0051798) | 4.72133497 |
| 29 | positive regulation of hair cycle (GO:0042635) | 4.72133497 |
| 30 | negative regulation of activin receptor signaling pathway (GO:0032926) | 4.61509837 |
| 31 | blastocyst development (GO:0001824) | 4.58489525 |
| 32 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.58272063 |
| 33 | regulation of hair follicle development (GO:0051797) | 4.55096751 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.48053641 |
| 35 | DNA deamination (GO:0045006) | 4.40578306 |
| 36 | positive regulation of ligase activity (GO:0051351) | 4.37523545 |
| 37 | histone arginine methylation (GO:0034969) | 4.30382230 |
| 38 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.21179480 |
| 39 | platelet dense granule organization (GO:0060155) | 4.21104953 |
| 40 | peptidyl-arginine N-methylation (GO:0035246) | 4.16460344 |
| 41 | peptidyl-arginine methylation (GO:0018216) | 4.16460344 |
| 42 | organelle disassembly (GO:1903008) | 4.16048524 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.13537052 |
| 44 | lymphoid progenitor cell differentiation (GO:0002320) | 4.13024775 |
| 45 | respiratory chain complex IV assembly (GO:0008535) | 4.12167143 |
| 46 | * anatomical structure arrangement (GO:0048532) | 4.07621613 |
| 47 | definitive hemopoiesis (GO:0060216) | 4.05685956 |
| 48 | regulation of cellular amine metabolic process (GO:0033238) | 4.04705240 |
| 49 | response to interferon-beta (GO:0035456) | 4.02003176 |
| 50 | positive regulation of cell cycle arrest (GO:0071158) | 4.00264350 |
| 51 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.89360868 |
| 52 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.88438414 |
| 53 | cellular response to estrogen stimulus (GO:0071391) | 3.81252864 |
| 54 | regulation of mitochondrial translation (GO:0070129) | 3.79159833 |
| 55 | regulation of ligase activity (GO:0051340) | 3.74935082 |
| 56 | daunorubicin metabolic process (GO:0044597) | 3.69368957 |
| 57 | polyketide metabolic process (GO:0030638) | 3.69368957 |
| 58 | doxorubicin metabolic process (GO:0044598) | 3.69368957 |
| 59 | protein deneddylation (GO:0000338) | 3.66953936 |
| 60 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 3.65687167 |
| 61 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 3.65687167 |
| 62 | cytochrome complex assembly (GO:0017004) | 3.64348205 |
| 63 | tRNA methylation (GO:0030488) | 3.63162596 |
| 64 | spliceosomal snRNP assembly (GO:0000387) | 3.59030631 |
| 65 | negative regulation of protein ubiquitination (GO:0031397) | 3.55103345 |
| 66 | viral transcription (GO:0019083) | 3.54493216 |
| 67 | paraxial mesoderm development (GO:0048339) | 3.53928457 |
| 68 | cranial nerve morphogenesis (GO:0021602) | 3.51026050 |
| 69 | purine ribonucleotide transport (GO:0015868) | 3.49772650 |
| 70 | regulation of cell cycle arrest (GO:0071156) | 3.48094605 |
| 71 | chaperone-mediated protein transport (GO:0072321) | 3.45757535 |
| 72 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.45087628 |
| 73 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.43414734 |
| 74 | cell cycle G1/S phase transition (GO:0044843) | 3.43414734 |
| 75 | adenine nucleotide transport (GO:0051503) | 3.38073924 |
| 76 | signal transduction in response to DNA damage (GO:0042770) | 3.37616560 |
| 77 | nucleotide transmembrane transport (GO:1901679) | 3.37027891 |
| 78 | DNA replication initiation (GO:0006270) | 3.34943730 |
| 79 | negative regulation of viral genome replication (GO:0045071) | 3.34503513 |
| 80 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.32802056 |
| 81 | translational termination (GO:0006415) | 3.32745387 |
| 82 | fat-soluble vitamin catabolic process (GO:0042363) | 3.29982311 |
| 83 | vitamin catabolic process (GO:0009111) | 3.29982311 |
| 84 | deoxyribonucleotide catabolic process (GO:0009264) | 3.27556859 |
| 85 | cullin deneddylation (GO:0010388) | 3.25097373 |
| 86 | GTP biosynthetic process (GO:0006183) | 3.23406596 |
| 87 | ribosomal small subunit biogenesis (GO:0042274) | 3.22517832 |
| 88 | maturation of SSU-rRNA (GO:0030490) | 3.21429422 |
| 89 | cranial nerve development (GO:0021545) | 3.19213298 |
| 90 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.19069453 |
| 91 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.15797988 |
| 92 | cerebellum development (GO:0021549) | 3.13997088 |
| 93 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.13729387 |
| 94 | CTP biosynthetic process (GO:0006241) | 3.12502337 |
| 95 | CTP metabolic process (GO:0046036) | 3.12502337 |
| 96 | nucleoside transmembrane transport (GO:1901642) | 3.11589654 |
| 97 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.10602870 |
| 98 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.10602870 |
| 99 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.10602870 |
| 100 | female gonad development (GO:0008585) | 3.10329661 |
| 101 | DNA strand elongation (GO:0022616) | 3.10132575 |
| 102 | outer ear morphogenesis (GO:0042473) | 3.09041298 |
| 103 | regulation of G1/S transition of mitotic cell cycle (GO:2000045) | 3.06634455 |
| 104 | spinal cord association neuron differentiation (GO:0021527) | 3.06606778 |
| 105 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.05887499 |
| 106 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.05597662 |
| 107 | non-recombinational repair (GO:0000726) | 3.05597662 |
| 108 | DNA damage response, detection of DNA damage (GO:0042769) | 3.04550161 |
| 109 | response to folic acid (GO:0051593) | 3.04104820 |
| 110 | regulation of cell cycle G1/S phase transition (GO:1902806) | 3.03841429 |
| 111 | mature B cell differentiation (GO:0002335) | 3.03496745 |
| 112 | base-excision repair (GO:0006284) | 3.02953538 |
| 113 | regulation of hair cycle (GO:0042634) | 3.02072169 |
| 114 | mesonephros development (GO:0001823) | 3.01359157 |
| 115 | cotranslational protein targeting to membrane (GO:0006613) | 3.00505489 |
| 116 | thyroid gland development (GO:0030878) | 2.99846898 |
| 117 | regulation of appetite (GO:0032098) | 2.99227124 |
| 118 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.98881818 |
| 119 | protein polyglutamylation (GO:0018095) | 2.97495151 |
| 120 | UTP biosynthetic process (GO:0006228) | 2.96781284 |
| 121 | protein targeting to ER (GO:0045047) | 2.95998379 |
| 122 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.93878737 |
| 123 | * facial nerve structural organization (GO:0021612) | 2.92037688 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91983955 |
| 125 | pseudouridine synthesis (GO:0001522) | 2.91061165 |
| 126 | deoxyribose phosphate catabolic process (GO:0046386) | 2.89995120 |
| 127 | mature B cell differentiation involved in immune response (GO:0002313) | 2.89830707 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.89382959 |
| 129 | DNA ligation (GO:0006266) | 2.87128159 |
| 130 | protein localization to endoplasmic reticulum (GO:0070972) | 2.86189714 |
| 131 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.85507834 |
| 132 | mannosylation (GO:0097502) | 2.84662613 |
| 133 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.82985945 |
| 134 | defense response to protozoan (GO:0042832) | 2.82263269 |
| 135 | response to interferon-alpha (GO:0035455) | 2.81147220 |
| 136 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.79901817 |
| 137 | RNA methylation (GO:0001510) | 2.79806898 |
| 138 | phospholipid scrambling (GO:0017121) | 2.79247476 |
| 139 | tRNA modification (GO:0006400) | 2.77418871 |
| 140 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.76248702 |
| 141 | megakaryocyte development (GO:0035855) | 2.74042304 |
| 142 | DNA replication checkpoint (GO:0000076) | 2.71869890 |
| 143 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.68359834 |
| 144 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.68359834 |
| 145 | translational elongation (GO:0006414) | 2.68343786 |
| 146 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.65547052 |
| 147 | postsynaptic membrane organization (GO:0001941) | 2.64747081 |
| 148 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.63987726 |
| 149 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.63987726 |
| 150 | T cell lineage commitment (GO:0002360) | 2.61583802 |
| 151 | ribosomal large subunit biogenesis (GO:0042273) | 2.60746976 |
| 152 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.60091257 |
| 153 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.59301971 |
| 154 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.59149411 |
| 155 | viral life cycle (GO:0019058) | 2.58307430 |
| 156 | centriole assembly (GO:0098534) | 2.57826287 |
| 157 | regulation of pigment cell differentiation (GO:0050932) | 2.55710056 |
| 158 | termination of RNA polymerase III transcription (GO:0006386) | 2.55583333 |
| 159 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.55583333 |
| 160 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.54997519 |
| 161 | secretory granule organization (GO:0033363) | 2.52968647 |
| 162 | GPI anchor biosynthetic process (GO:0006506) | 2.52855534 |
| 163 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.46111453 |
| 164 | fucose catabolic process (GO:0019317) | 2.44461639 |
| 165 | L-fucose metabolic process (GO:0042354) | 2.44461639 |
| 166 | L-fucose catabolic process (GO:0042355) | 2.44461639 |
| 167 | presynaptic membrane assembly (GO:0097105) | 2.44075972 |
| 168 | response to protozoan (GO:0001562) | 2.43929644 |
| 169 | viral genome replication (GO:0019079) | 2.42456798 |
| 170 | cartilage morphogenesis (GO:0060536) | 2.41763816 |
| 171 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.40971907 |
| 172 | viral mRNA export from host cell nucleus (GO:0046784) | 2.40122234 |
| 173 | cellular protein complex disassembly (GO:0043624) | 2.39550526 |
| 174 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.39504384 |
| 175 | RNA capping (GO:0036260) | 2.38976844 |
| 176 | 7-methylguanosine RNA capping (GO:0009452) | 2.38976844 |
| 177 | tRNA processing (GO:0008033) | 2.37419747 |
| 178 | endothelium development (GO:0003158) | 2.35049746 |
| 179 | intra-S DNA damage checkpoint (GO:0031573) | 2.34507829 |
| 180 | cellular response to interferon-beta (GO:0035458) | 2.34439328 |
| 181 | meiotic chromosome segregation (GO:0045132) | 2.34419821 |
| 182 | RNA modification (GO:0009451) | 2.33604396 |
| 183 | telomere maintenance via recombination (GO:0000722) | 2.33065658 |
| 184 | 7-methylguanosine mRNA capping (GO:0006370) | 2.32435878 |
| 185 | response to peptidoglycan (GO:0032494) | 2.31446737 |
| 186 | omega-hydroxylase P450 pathway (GO:0097267) | 2.30582763 |
| 187 | short-term memory (GO:0007614) | 2.29923658 |
| 188 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.27730789 |
| 189 | reciprocal DNA recombination (GO:0035825) | 2.26938608 |
| 190 | reciprocal meiotic recombination (GO:0007131) | 2.26938608 |
| 191 | granulocyte differentiation (GO:0030851) | 2.26775431 |
| 192 | B cell differentiation (GO:0030183) | 2.26620527 |
| 193 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.26081541 |
| 194 | specification of organ identity (GO:0010092) | 2.25569595 |
| 195 | peristalsis (GO:0030432) | 11.2058152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.72369574 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.87115329 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.41429286 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.24819285 |
| 5 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.08642281 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88957659 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.85968695 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64171340 |
| 9 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 2.57704411 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.57344559 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.55014481 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45919291 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38775478 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.25786334 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24141324 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23108984 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.22613007 |
| 18 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.21376069 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17704723 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.15693579 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.15439310 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.13700106 |
| 23 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.10891785 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.09748578 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05203796 |
| 26 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.03992395 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03933991 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.00652724 |
| 29 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.99453592 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99092661 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98844759 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95576086 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91285671 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.90688889 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.89502563 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87232579 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.85965791 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85867602 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.84605819 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.81129803 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76499046 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75674216 |
| 43 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.74726108 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.73534084 |
| 45 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.72250527 |
| 46 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.72052194 |
| 47 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.70853021 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.67530980 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66575036 |
| 50 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.66508587 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66102074 |
| 52 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.64523934 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.64102048 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64089908 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63384860 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62856951 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61553141 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61476917 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.56234686 |
| 60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.52697652 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.51493000 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49916818 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48757344 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47923938 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46443400 |
| 66 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44576644 |
| 67 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43997617 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40633799 |
| 69 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40093743 |
| 70 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38662773 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38077287 |
| 72 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35736739 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34742307 |
| 74 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.33385484 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32560525 |
| 76 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.31361158 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.28767063 |
| 78 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.28697221 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27793462 |
| 80 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27705181 |
| 81 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.26832672 |
| 82 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.26755028 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26720151 |
| 84 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.25767241 |
| 85 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.24608021 |
| 86 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24451408 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23989477 |
| 88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22503098 |
| 89 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.22453031 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22339607 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22223162 |
| 92 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22024373 |
| 93 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.21967500 |
| 94 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21152000 |
| 95 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20551090 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19910774 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19829827 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19605613 |
| 99 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19594139 |
| 100 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.19176969 |
| 101 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18756266 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18080936 |
| 103 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17802392 |
| 104 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17802392 |
| 105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17802392 |
| 106 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16684017 |
| 107 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16512549 |
| 108 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16175580 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13141754 |
| 110 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12156086 |
| 111 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11926496 |
| 112 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.11902153 |
| 113 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.11460589 |
| 114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11259482 |
| 115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10185845 |
| 116 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.10123376 |
| 117 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.09955833 |
| 118 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09616900 |
| 119 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09359626 |
| 120 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08518357 |
| 121 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08310525 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07987896 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07462225 |
| 124 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06280228 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05761966 |
| 126 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05640167 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05260760 |
| 128 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04979223 |
| 129 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.04057567 |
| 130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03754901 |
| 131 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03386244 |
| 132 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03320410 |
| 133 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03268819 |
| 134 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03147701 |
| 135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01987052 |
| 136 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01460040 |
| 137 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.01038624 |
| 138 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99683045 |
| 139 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98258242 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.96001163 |
| 141 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.95942407 |
| 142 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95879861 |
| 143 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.94735223 |
| 144 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94358688 |
| 145 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93159524 |
| 146 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91808631 |
| 147 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.91169872 |
| 148 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90960741 |
| 149 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90860759 |
| 150 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90803041 |
| 151 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90698189 |
| 152 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90696803 |
| 153 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90270028 |
| 154 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89964804 |
| 155 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.89935030 |
| 156 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.87688939 |
| 157 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86494567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005167_abnormal_blood-brain_barrier | 7.84301112 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.59432338 |
| 3 | MP0003136_yellow_coat_color | 4.17141195 |
| 4 | MP0001188_hyperpigmentation | 3.98631634 |
| 5 | MP0008789_abnormal_olfactory_epithelium | 3.26114657 |
| 6 | MP0005451_abnormal_body_composition | 3.11902175 |
| 7 | MP0005409_darkened_coat_color | 2.98001374 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.87130446 |
| 9 | MP0002254_reproductive_system_inflammat | 2.81462525 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.81225372 |
| 11 | MP0003283_abnormal_digestive_organ | 2.80646999 |
| 12 | MP0004381_abnormal_hair_follicle | 2.77917152 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.75668935 |
| 14 | MP0005499_abnormal_olfactory_system | 2.69362152 |
| 15 | MP0005394_taste/olfaction_phenotype | 2.69362152 |
| 16 | MP0003787_abnormal_imprinting | 2.61771980 |
| 17 | MP0002102_abnormal_ear_morphology | 2.59869905 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.41536156 |
| 19 | MP0002249_abnormal_larynx_morphology | 2.33238787 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.32024407 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.29203792 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.24672778 |
| 23 | MP0003878_abnormal_ear_physiology | 2.13460654 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 2.13460654 |
| 25 | MP0009697_abnormal_copulation | 2.01938052 |
| 26 | MP0004133_heterotaxia | 1.98462597 |
| 27 | MP0003724_increased_susceptibility_to | 1.95943004 |
| 28 | MP0000049_abnormal_middle_ear | 1.91946699 |
| 29 | MP0001727_abnormal_embryo_implantation | 1.90916456 |
| 30 | MP0009785_altered_susceptibility_to | 1.84576057 |
| 31 | MP0008058_abnormal_DNA_repair | 1.83595326 |
| 32 | MP0002095_abnormal_skin_pigmentation | 1.83268181 |
| 33 | MP0005253_abnormal_eye_physiology | 1.78336273 |
| 34 | * MP0004924_abnormal_behavior | 1.76290060 |
| 35 | * MP0005386_behavior/neurological_phenoty | 1.76290060 |
| 36 | MP0005671_abnormal_response_to | 1.75942843 |
| 37 | MP0000343_altered_response_to | 1.75794619 |
| 38 | MP0003119_abnormal_digestive_system | 1.75776024 |
| 39 | MP0001529_abnormal_vocalization | 1.75338630 |
| 40 | MP0002233_abnormal_nose_morphology | 1.74866352 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.74129370 |
| 42 | MP0006054_spinal_hemorrhage | 1.70250362 |
| 43 | MP0000566_synostosis | 1.65744166 |
| 44 | MP0003718_maternal_effect | 1.64351585 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.62893434 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.62569041 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.61965219 |
| 48 | MP0002938_white_spotting | 1.56073773 |
| 49 | MP0002822_catalepsy | 1.53391252 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.52345456 |
| 51 | MP0000681_abnormal_thyroid_gland | 1.49835257 |
| 52 | MP0004147_increased_porphyrin_level | 1.49820670 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.49348261 |
| 54 | MP0002177_abnormal_outer_ear | 1.48850841 |
| 55 | MP0000490_abnormal_crypts_of | 1.46221069 |
| 56 | MP0003315_abnormal_perineum_morphology | 1.45770522 |
| 57 | MP0003938_abnormal_ear_development | 1.44625262 |
| 58 | MP0000685_abnormal_immune_system | 1.43798291 |
| 59 | MP0001346_abnormal_lacrimal_gland | 1.42712116 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.40206586 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.40189832 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.37012035 |
| 63 | MP0002132_abnormal_respiratory_system | 1.36912957 |
| 64 | MP0001730_embryonic_growth_arrest | 1.36636518 |
| 65 | MP0005171_absent_coat_pigmentation | 1.35532493 |
| 66 | MP0005248_abnormal_Harderian_gland | 1.32042016 |
| 67 | MP0005025_abnormal_response_to | 1.30485789 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.28155543 |
| 69 | MP0002734_abnormal_mechanical_nocicepti | 1.25881144 |
| 70 | MP0008260_abnormal_autophagy | 1.23653283 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.22038691 |
| 72 | MP0001853_heart_inflammation | 1.19884674 |
| 73 | * MP0000428_abnormal_craniofacial_morphol | 1.18443112 |
| 74 | MP0004142_abnormal_muscle_tone | 1.18154313 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.14251750 |
| 76 | MP0001800_abnormal_humoral_immune | 1.12116799 |
| 77 | * MP0002752_abnormal_somatic_nervous | 1.10732383 |
| 78 | MP0008007_abnormal_cellular_replicative | 1.10601347 |
| 79 | MP0002876_abnormal_thyroid_physiology | 1.09937646 |
| 80 | MP0002723_abnormal_immune_serum | 1.09903797 |
| 81 | MP0002452_abnormal_antigen_presenting | 1.09319957 |
| 82 | MP0002009_preneoplasia | 1.07744240 |
| 83 | MP0003121_genomic_imprinting | 1.06765729 |
| 84 | MP0001545_abnormal_hematopoietic_system | 1.06619095 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 1.06619095 |
| 86 | MP0003880_abnormal_central_pattern | 1.06452830 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 1.05259339 |
| 88 | MP0002932_abnormal_joint_morphology | 1.05057458 |
| 89 | MP0005000_abnormal_immune_tolerance | 1.04767980 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.04598970 |
| 91 | MP0001819_abnormal_immune_cell | 1.04579027 |
| 92 | MP0003111_abnormal_nucleus_morphology | 1.03447833 |
| 93 | MP0002160_abnormal_reproductive_system | 1.02910730 |
| 94 | MP0003646_muscle_fatigue | 1.01821525 |
| 95 | MP0003077_abnormal_cell_cycle | 1.01813666 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 1.01101651 |
| 97 | MP0006072_abnormal_retinal_apoptosis | 1.00928554 |
| 98 | MP0002111_abnormal_tail_morphology | 1.00910215 |
| 99 | MP0002419_abnormal_innate_immunity | 0.99175545 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.98277539 |
| 101 | MP0002398_abnormal_bone_marrow | 0.97147990 |
| 102 | MP0003786_premature_aging | 0.95786729 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95730857 |
| 104 | MP0005646_abnormal_pituitary_gland | 0.93978219 |
| 105 | MP0005391_vision/eye_phenotype | 0.93778612 |
| 106 | MP0002557_abnormal_social/conspecific_i | 0.92495043 |
| 107 | MP0008057_abnormal_DNA_replication | 0.92030509 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.90885663 |
| 109 | MP0000026_abnormal_inner_ear | 0.90250237 |
| 110 | MP0001873_stomach_inflammation | 0.88804547 |
| 111 | MP0002163_abnormal_gland_morphology | 0.88570625 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.87840802 |
| 113 | MP0009672_abnormal_birth_weight | 0.87693058 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.87130080 |
| 115 | MP0001293_anophthalmia | 0.86261690 |
| 116 | MP0000716_abnormal_immune_system | 0.85773722 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.83877806 |
| 118 | MP0002272_abnormal_nervous_system | 0.83641696 |
| 119 | MP0009250_abnormal_appendicular_skeleto | 0.83392962 |
| 120 | MP0000751_myopathy | 0.83139076 |
| 121 | MP0008932_abnormal_embryonic_tissue | 0.83111254 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.81318938 |
| 123 | MP0010094_abnormal_chromosome_stability | 0.80915552 |
| 124 | MP0002085_abnormal_embryonic_tissue | 0.80828533 |
| 125 | MP0002722_abnormal_immune_system | 0.80596032 |
| 126 | MP0001919_abnormal_reproductive_system | 0.80418983 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.80202227 |
| 128 | MP0001905_abnormal_dopamine_level | 0.80200512 |
| 129 | MP0003861_abnormal_nervous_system | 0.79845886 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.78126152 |
| 131 | MP0003935_abnormal_craniofacial_develop | 0.77357834 |
| 132 | MP0003385_abnormal_body_wall | 0.77263115 |
| 133 | MP0003755_abnormal_palate_morphology | 0.76921207 |
| 134 | MP0008995_early_reproductive_senescence | 0.76521116 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.76489355 |
| 136 | * MP0001486_abnormal_startle_reflex | 0.75819972 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.75479360 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.75393130 |
| 139 | MP0005083_abnormal_biliary_tract | 0.75283032 |
| 140 | MP0001790_abnormal_immune_system | 0.75136788 |
| 141 | MP0005387_immune_system_phenotype | 0.75136788 |
| 142 | MP0003866_abnormal_defecation | 0.73923959 |
| 143 | MP0001485_abnormal_pinna_reflex | 0.73862580 |
| 144 | MP0002429_abnormal_blood_cell | 0.73638079 |
| 145 | * MP0000432_abnormal_head_morphology | 0.73254292 |
| 146 | MP0005195_abnormal_posterior_eye | 0.73211820 |
| 147 | MP0002114_abnormal_axial_skeleton | 0.73089472 |
| 148 | MP0001119_abnormal_female_reproductive | 0.72617393 |
| 149 | MP0009046_muscle_twitch | 0.72399332 |
| 150 | MP0000631_abnormal_neuroendocrine_gland | 0.72291031 |
| 151 | MP0002210_abnormal_sex_determination | 0.71645843 |
| 152 | MP0004859_abnormal_synaptic_plasticity | 0.71068610 |
| 153 | MP0001984_abnormal_olfaction | 0.70729319 |
| 154 | MP0003011_delayed_dark_adaptation | 0.70580271 |
| 155 | MP0002084_abnormal_developmental_patter | 0.70554774 |
| 156 | MP0004215_abnormal_myocardial_fiber | 0.69645253 |
| 157 | MP0002282_abnormal_trachea_morphology | 0.68661071 |
| 158 | MP0003941_abnormal_skin_development | 0.68520083 |
| 159 | MP0001663_abnormal_digestive_system | 0.68476486 |
| 160 | MP0002075_abnormal_coat/hair_pigmentati | 0.67216406 |
| 161 | MP0001348_abnormal_lacrimal_gland | 0.67038993 |
| 162 | MP0000955_abnormal_spinal_cord | 0.66996231 |
| 163 | MP0005389_reproductive_system_phenotype | 0.66882068 |
| 164 | MP0005084_abnormal_gallbladder_morpholo | 0.66650357 |
| 165 | MP0010368_abnormal_lymphatic_system | 0.65487143 |
| 166 | MP0003122_maternal_imprinting | 0.62087069 |
| 167 | MP0000163_abnormal_cartilage_morphology | 0.58819258 |
| 168 | MP0000762_abnormal_tongue_morphology | 0.58331571 |
| 169 | MP0002184_abnormal_innervation | 0.57988527 |
| 170 | MP0003633_abnormal_nervous_system | 0.57045485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Facial cleft (HP:0002006) | 6.35852960 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 4.36040612 |
| 3 | Reduced antithrombin III activity (HP:0001976) | 3.82046653 |
| 4 | Type 2 muscle fiber atrophy (HP:0003554) | 3.78003198 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 3.71125095 |
| 6 | Absent eyebrow (HP:0002223) | 3.68700430 |
| 7 | Myelomeningocele (HP:0002475) | 3.63586010 |
| 8 | Abnormality of the axillary hair (HP:0100134) | 3.58770725 |
| 9 | Abnormality of secondary sexual hair (HP:0009888) | 3.58770725 |
| 10 | Proximal placement of thumb (HP:0009623) | 3.58747973 |
| 11 | 3-Methylglutaconic aciduria (HP:0003535) | 3.53042705 |
| 12 | Abnormal number of erythroid precursors (HP:0012131) | 3.52032699 |
| 13 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 3.51577516 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.42341355 |
| 15 | Vaginal atresia (HP:0000148) | 3.39693994 |
| 16 | Morphological abnormality of the middle ear (HP:0008609) | 3.33956248 |
| 17 | Muscle fiber atrophy (HP:0100295) | 3.32679704 |
| 18 | Abnormality of the labia minora (HP:0012880) | 3.32589518 |
| 19 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.25433945 |
| 20 | Aplastic anemia (HP:0001915) | 3.21545674 |
| 21 | Genital tract atresia (HP:0001827) | 3.19834774 |
| 22 | Anophthalmia (HP:0000528) | 3.10326137 |
| 23 | Supernumerary spleens (HP:0009799) | 3.08779697 |
| 24 | Abnormality of the pubic bones (HP:0003172) | 3.06694305 |
| 25 | Bilateral microphthalmos (HP:0007633) | 3.05792457 |
| 26 | Abnormality of macular pigmentation (HP:0008002) | 3.05178421 |
| 27 | Deviation of the thumb (HP:0009603) | 3.02148197 |
| 28 | Stenosis of the external auditory canal (HP:0000402) | 2.99208715 |
| 29 | Meningocele (HP:0002435) | 2.97425544 |
| 30 | Methylmalonic aciduria (HP:0012120) | 2.94671698 |
| 31 | Chromsome breakage (HP:0040012) | 2.94213011 |
| 32 | Labial hypoplasia (HP:0000066) | 2.90571799 |
| 33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.88795620 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.88795620 |
| 35 | Abnormal protein glycosylation (HP:0012346) | 2.88795620 |
| 36 | Abnormal glycosylation (HP:0012345) | 2.88795620 |
| 37 | Reticulocytopenia (HP:0001896) | 2.85162259 |
| 38 | Cutaneous finger syndactyly (HP:0010554) | 2.82626737 |
| 39 | Abnormal number of incisors (HP:0011064) | 2.81921930 |
| 40 | Mixed hearing impairment (HP:0000410) | 2.80845530 |
| 41 | Patchy hypopigmentation of hair (HP:0011365) | 2.80004622 |
| 42 | * Nonprogressive disorder (HP:0003680) | 2.77637052 |
| 43 | Asplenia (HP:0001746) | 2.76944270 |
| 44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.75677552 |
| 45 | Hypoplastic female external genitalia (HP:0012815) | 2.74865578 |
| 46 | Colon cancer (HP:0003003) | 2.74269761 |
| 47 | Cutaneous syndactyly (HP:0012725) | 2.72921649 |
| 48 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.71919932 |
| 49 | Absent hair (HP:0002298) | 2.71602047 |
| 50 | Bifid tongue (HP:0010297) | 2.71183671 |
| 51 | True hermaphroditism (HP:0010459) | 2.67626026 |
| 52 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.66069661 |
| 53 | Bicornuate uterus (HP:0000813) | 2.62571046 |
| 54 | Dyschromatopsia (HP:0007641) | 2.61943056 |
| 55 | Dry hair (HP:0011359) | 2.61380530 |
| 56 | Thyroid-stimulating hormone excess (HP:0002925) | 2.61057457 |
| 57 | Thoracolumbar scoliosis (HP:0002944) | 2.60423453 |
| 58 | Abnormality of the lacrimal duct (HP:0011481) | 2.59587755 |
| 59 | Selective tooth agenesis (HP:0001592) | 2.55489648 |
| 60 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.54049987 |
| 61 | Choanal stenosis (HP:0000452) | 2.50116879 |
| 62 | Glossoptosis (HP:0000162) | 2.46534366 |
| 63 | Microvesicular hepatic steatosis (HP:0001414) | 2.43208294 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.41136498 |
| 65 | Microretrognathia (HP:0000308) | 2.41036253 |
| 66 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.40227449 |
| 67 | Mesomelia (HP:0003027) | 2.40205641 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 2.39325939 |
| 69 | Abnormal lung lobation (HP:0002101) | 2.38465873 |
| 70 | Meckel diverticulum (HP:0002245) | 2.37726943 |
| 71 | White forelock (HP:0002211) | 2.37323938 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.34571149 |
| 73 | Abnormality of the lumbar spine (HP:0100712) | 2.34513071 |
| 74 | Cerebral hypomyelination (HP:0006808) | 2.33977585 |
| 75 | Gait imbalance (HP:0002141) | 2.33901795 |
| 76 | Hypoplastic labia majora (HP:0000059) | 2.33074702 |
| 77 | Disproportionate short-trunk short stature (HP:0003521) | 2.32052234 |
| 78 | Increased hepatocellular lipid droplets (HP:0006565) | 2.30934948 |
| 79 | Hypothermia (HP:0002045) | 2.30810039 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.26889761 |
| 81 | Cleft eyelid (HP:0000625) | 2.26209884 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.26095368 |
| 83 | Abnormality of the ileum (HP:0001549) | 2.23016326 |
| 84 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.22521289 |
| 85 | Abnormality of abdominal situs (HP:0011620) | 2.20151639 |
| 86 | Abdominal situs inversus (HP:0003363) | 2.20151639 |
| 87 | Median cleft lip (HP:0000161) | 2.19155352 |
| 88 | Vitreoretinal degeneration (HP:0000655) | 2.19023162 |
| 89 | Intestinal atresia (HP:0011100) | 2.18849499 |
| 90 | Clubbing of toes (HP:0100760) | 2.18523638 |
| 91 | Petechiae (HP:0000967) | 2.18324071 |
| 92 | Ectopic anus (HP:0004397) | 2.15764772 |
| 93 | Weak cry (HP:0001612) | 2.15239729 |
| 94 | Medial flaring of the eyebrow (HP:0010747) | 2.14720110 |
| 95 | Abnormal sex determination (HP:0012244) | 2.12257146 |
| 96 | Sex reversal (HP:0012245) | 2.12257146 |
| 97 | Abnormality of the preputium (HP:0100587) | 2.11739100 |
| 98 | Abnormal ciliary motility (HP:0012262) | 2.10501469 |
| 99 | Pallor (HP:0000980) | 2.07771219 |
| 100 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.07727750 |
| 101 | Acute necrotizing encephalopathy (HP:0006965) | 2.07321316 |
| 102 | Abnormality of the labia majora (HP:0012881) | 2.06862174 |
| 103 | Abnormality of the nasolacrimal system (HP:0000614) | 2.06060009 |
| 104 | Abnormality of the columella (HP:0009929) | 2.05265246 |
| 105 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03857123 |
| 106 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03857123 |
| 107 | Hepatocellular necrosis (HP:0001404) | 2.03591670 |
| 108 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.02938014 |
| 109 | Synostosis of carpal bones (HP:0005048) | 2.02379665 |
| 110 | Hemivertebrae (HP:0002937) | 2.01968463 |
| 111 | Cellular immunodeficiency (HP:0005374) | 2.01624106 |
| 112 | Abnormality of the labia (HP:0000058) | 2.01076828 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00600211 |
| 114 | Omphalocele (HP:0001539) | 2.00149575 |
| 115 | Myositis (HP:0100614) | 1.99845994 |
| 116 | Meningitis (HP:0001287) | 1.99166123 |
| 117 | Acute encephalopathy (HP:0006846) | 1.98678601 |
| 118 | Chin dimple (HP:0010751) | 1.98129240 |
| 119 | Attenuation of retinal blood vessels (HP:0007843) | 1.97901557 |
| 120 | Nephronophthisis (HP:0000090) | 1.96352938 |
| 121 | Beaking of vertebral bodies (HP:0004568) | 1.96216461 |
| 122 | Thrombocytosis (HP:0001894) | 1.95947243 |
| 123 | High anterior hairline (HP:0009890) | 1.95517949 |
| 124 | Exertional dyspnea (HP:0002875) | 1.95196646 |
| 125 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.94580705 |
| 126 | Severe visual impairment (HP:0001141) | 1.94074275 |
| 127 | Broad foot (HP:0001769) | 1.93354701 |
| 128 | Abnormality of the pulmonary veins (HP:0011718) | 1.93187728 |
| 129 | Bile duct proliferation (HP:0001408) | 1.92707366 |
| 130 | Abnormal biliary tract physiology (HP:0012439) | 1.92707366 |
| 131 | Midline defect of the nose (HP:0004122) | 1.92423112 |
| 132 | Triphalangeal thumb (HP:0001199) | 1.92001639 |
| 133 | Cupped ear (HP:0000378) | 1.91928315 |
| 134 | Absent eyelashes (HP:0000561) | 1.91654263 |
| 135 | Short tibia (HP:0005736) | 1.90303460 |
| 136 | Medulloblastoma (HP:0002885) | 1.89786620 |
| 137 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.89381440 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 1.89381440 |
| 139 | Rhabdomyosarcoma (HP:0002859) | 1.88308832 |
| 140 | Optic nerve hypoplasia (HP:0000609) | 1.87914178 |
| 141 | Macrocytic anemia (HP:0001972) | 1.87249408 |
| 142 | Abnormality of the parietal bone (HP:0002696) | 1.87023413 |
| 143 | Pancreatic fibrosis (HP:0100732) | 1.86928247 |
| 144 | Broad thumb (HP:0011304) | 1.86004947 |
| 145 | Broad metatarsal (HP:0001783) | 1.85959789 |
| 146 | Facial diplegia (HP:0001349) | 1.85229960 |
| 147 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85201617 |
| 148 | Horseshoe kidney (HP:0000085) | 1.84181175 |
| 149 | Partial duplication of the phalanx of hand (HP:0009999) | 1.83329988 |
| 150 | Central scotoma (HP:0000603) | 1.82418286 |
| 151 | Mediastinal lymphadenopathy (HP:0100721) | 1.82286136 |
| 152 | Short middle phalanx of the 5th finger (HP:0004220) | 1.82215666 |
| 153 | Pancytopenia (HP:0001876) | 1.81435679 |
| 154 | Anomalous pulmonary venous return (HP:0010772) | 1.80858217 |
| 155 | Pigmentary retinal degeneration (HP:0001146) | 1.80840782 |
| 156 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.80784174 |
| 157 | Optic neuritis (HP:0100653) | 1.80513559 |
| 158 | Retrobulbar optic neuritis (HP:0100654) | 1.80513559 |
| 159 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.80312172 |
| 160 | Mitochondrial inheritance (HP:0001427) | 1.79787463 |
| 161 | Rib fusion (HP:0000902) | 1.79333310 |
| 162 | Prostate neoplasm (HP:0100787) | 1.77854523 |
| 163 | Partial duplication of thumb phalanx (HP:0009944) | 1.77421971 |
| 164 | Thoracic kyphosis (HP:0002942) | 1.77401489 |
| 165 | Microtia (HP:0008551) | 1.77172000 |
| 166 | Renal hypoplasia (HP:0000089) | 1.76860262 |
| 167 | Abnormality of DNA repair (HP:0003254) | 1.76556898 |
| 168 | Preaxial hand polydactyly (HP:0001177) | 1.75763403 |
| 169 | Agammaglobulinemia (HP:0004432) | 1.75306775 |
| 170 | Epistaxis (HP:0000421) | 1.74897011 |
| 171 | Recurrent abscess formation (HP:0002722) | 1.74172899 |
| 172 | IgM deficiency (HP:0002850) | 1.73274393 |
| 173 | Myelodysplasia (HP:0002863) | 1.73011158 |
| 174 | Optic disc pallor (HP:0000543) | 1.72629076 |
| 175 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71672080 |
| 176 | Obstructive lung disease (HP:0006536) | 1.71672080 |
| 177 | Abnormality of chromosome stability (HP:0003220) | 1.71031468 |
| 178 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.70920523 |
| 179 | Pancreatic cysts (HP:0001737) | 1.70286158 |
| 180 | Hypergonadotropic hypogonadism (HP:0000815) | 1.69544557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 6.34838615 |
| 2 | CASK | 4.75670955 |
| 3 | MAP3K4 | 4.58573079 |
| 4 | EPHA4 | 4.38098737 |
| 5 | MKNK2 | 3.98765587 |
| 6 | TNIK | 3.34171933 |
| 7 | MKNK1 | 3.27615474 |
| 8 | STK16 | 3.21899349 |
| 9 | SRPK1 | 2.66989532 |
| 10 | NME2 | 2.55197915 |
| 11 | TLK1 | 2.54336835 |
| 12 | TXK | 2.10676640 |
| 13 | IRAK4 | 2.08111552 |
| 14 | CDK19 | 2.05122657 |
| 15 | MAP2K4 | 1.85924675 |
| 16 | BRD4 | 1.82253943 |
| 17 | MAP4K2 | 1.76552100 |
| 18 | TEC | 1.76292985 |
| 19 | IRAK3 | 1.66675077 |
| 20 | NLK | 1.59742927 |
| 21 | CSNK1A1L | 1.56070604 |
| 22 | KIT | 1.52350270 |
| 23 | STK38L | 1.52304770 |
| 24 | STK24 | 1.48632831 |
| 25 | VRK1 | 1.47149161 |
| 26 | ADRBK2 | 1.45347785 |
| 27 | GRK1 | 1.39621637 |
| 28 | CSNK1G2 | 1.36842000 |
| 29 | TIE1 | 1.35309918 |
| 30 | NME1 | 1.34301591 |
| 31 | CDC7 | 1.31126844 |
| 32 | PRKG2 | 1.23010563 |
| 33 | YES1 | 1.21980371 |
| 34 | EIF2AK2 | 1.21540412 |
| 35 | MAP3K12 | 1.18362720 |
| 36 | BTK | 1.18055461 |
| 37 | MAP2K7 | 1.14178112 |
| 38 | PLK2 | 1.11971380 |
| 39 | TGFBR2 | 1.06410815 |
| 40 | CDK8 | 1.06353801 |
| 41 | BLK | 1.05749732 |
| 42 | MAP4K1 | 1.05524020 |
| 43 | CLK1 | 1.04025891 |
| 44 | IKBKB | 1.03949691 |
| 45 | PLK4 | 1.03547291 |
| 46 | MAP3K14 | 1.02620348 |
| 47 | MAPKAPK5 | 0.99102277 |
| 48 | CDK3 | 0.96084584 |
| 49 | IKBKE | 0.95777063 |
| 50 | ZAK | 0.90813711 |
| 51 | NEK6 | 0.90595556 |
| 52 | PRPF4B | 0.90592836 |
| 53 | BMPR1B | 0.89648030 |
| 54 | CAMKK2 | 0.86629138 |
| 55 | VRK2 | 0.84895183 |
| 56 | PRKD2 | 0.84505630 |
| 57 | PLK3 | 0.84368056 |
| 58 | BCR | 0.83234899 |
| 59 | IRAK1 | 0.83090990 |
| 60 | IRAK2 | 0.82894662 |
| 61 | BRSK1 | 0.81708853 |
| 62 | EIF2AK3 | 0.81432994 |
| 63 | GRK7 | 0.80346871 |
| 64 | CSNK1G1 | 0.79775475 |
| 65 | CDK7 | 0.77984479 |
| 66 | DYRK3 | 0.76871091 |
| 67 | BCKDK | 0.76096693 |
| 68 | PIM2 | 0.75589609 |
| 69 | PIM1 | 0.70602195 |
| 70 | TGFBR1 | 0.68220832 |
| 71 | MAPK13 | 0.66567769 |
| 72 | RPS6KA5 | 0.66283367 |
| 73 | CDK12 | 0.65356345 |
| 74 | EIF2AK1 | 0.64999328 |
| 75 | LYN | 0.64157549 |
| 76 | BMPR2 | 0.63018669 |
| 77 | MAP2K6 | 0.62843720 |
| 78 | BMX | 0.62756181 |
| 79 | CDK9 | 0.62042668 |
| 80 | CAMK1 | 0.61744561 |
| 81 | TRIM28 | 0.60044999 |
| 82 | MYLK | 0.59840167 |
| 83 | PLK1 | 0.59461395 |
| 84 | SYK | 0.59012133 |
| 85 | DAPK1 | 0.58831967 |
| 86 | NTRK3 | 0.56098028 |
| 87 | TNK2 | 0.54029369 |
| 88 | MST4 | 0.53217411 |
| 89 | PINK1 | 0.52133813 |
| 90 | MATK | 0.51737897 |
| 91 | FLT3 | 0.51512686 |
| 92 | CSF1R | 0.51165917 |
| 93 | TESK1 | 0.51149203 |
| 94 | CHEK2 | 0.48096229 |
| 95 | FES | 0.48012275 |
| 96 | TAOK2 | 0.47377561 |
| 97 | PAK4 | 0.47276672 |
| 98 | PBK | 0.46401265 |
| 99 | TESK2 | 0.46238244 |
| 100 | KDR | 0.44291922 |
| 101 | PIK3CG | 0.44129727 |
| 102 | EPHB2 | 0.43632213 |
| 103 | BRSK2 | 0.42609074 |
| 104 | UHMK1 | 0.40742578 |
| 105 | CDK6 | 0.40081974 |
| 106 | FER | 0.40071828 |
| 107 | PDK2 | 0.39679213 |
| 108 | JAK3 | 0.38518662 |
| 109 | WEE1 | 0.38362504 |
| 110 | ERBB3 | 0.37650985 |
| 111 | CSNK2A1 | 0.36974177 |
| 112 | INSRR | 0.36497195 |
| 113 | BUB1 | 0.35106455 |
| 114 | CHUK | 0.34792667 |
| 115 | MAPK4 | 0.34093767 |
| 116 | DYRK1B | 0.34025852 |
| 117 | WNK3 | 0.33953691 |
| 118 | CHEK1 | 0.33589013 |
| 119 | CSNK1G3 | 0.32422622 |
| 120 | ATM | 0.32380192 |
| 121 | RPS6KA4 | 0.32372214 |
| 122 | LCK | 0.32045230 |
| 123 | TTK | 0.32012961 |
| 124 | TBK1 | 0.31659267 |
| 125 | SGK2 | 0.30355770 |
| 126 | MAPK11 | 0.29976413 |
| 127 | EGFR | 0.28593905 |
| 128 | RPS6KB1 | 0.28551206 |
| 129 | LIMK1 | 0.28528254 |
| 130 | FGFR2 | 0.28369332 |
| 131 | ATR | 0.27262297 |
| 132 | HIPK2 | 0.26507791 |
| 133 | RPS6KA6 | 0.26221728 |
| 134 | NEK2 | 0.26176848 |
| 135 | MAP3K5 | 0.25422305 |
| 136 | MAP2K3 | 0.25305516 |
| 137 | ZAP70 | 0.24455953 |
| 138 | DYRK1A | 0.24285600 |
| 139 | AKT3 | 0.23871455 |
| 140 | ACVR1B | 0.23835748 |
| 141 | RPS6KL1 | 0.23673128 |
| 142 | RPS6KC1 | 0.23673128 |
| 143 | DYRK2 | 0.23367662 |
| 144 | DAPK2 | 0.22139942 |
| 145 | CAMK1D | 0.22057980 |
| 146 | CDK5 | 0.22003074 |
| 147 | NEK9 | 0.22000794 |
| 148 | CAMK4 | 0.21964263 |
| 149 | NUAK1 | 0.21784325 |
| 150 | PIK3CA | 0.20282711 |
| 151 | CDK14 | 0.19982099 |
| 152 | CSNK2A2 | 0.19723829 |
| 153 | CDK2 | 0.16604121 |
| 154 | MAPK9 | 0.16473059 |
| 155 | MINK1 | 0.16116020 |
| 156 | CSNK1A1 | 0.14568164 |
| 157 | CSK | 0.14239905 |
| 158 | STK3 | 0.12655845 |
| 159 | CDK18 | 0.12646562 |
| 160 | AURKA | 0.12585122 |
| 161 | CSNK1E | 0.12494617 |
| 162 | MAPK10 | 0.11501935 |
| 163 | ERBB2 | 0.10359543 |
| 164 | ABL2 | 0.10162740 |
| 165 | MAP3K6 | 0.09814643 |
| 166 | CDK15 | 0.09702768 |
| 167 | PTK6 | 0.09694077 |
| 168 | CDK1 | 0.09069659 |
| 169 | EPHA2 | 0.08937462 |
| 170 | CDK11A | 0.08784879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.06450466 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.05763411 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.69684227 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.60483989 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.51058877 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.49641136 |
| 7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.42697546 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.21601538 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.21000976 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.10285919 |
| 11 | Basal transcription factors_Homo sapiens_hsa03022 | 2.04345235 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.01974439 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.99585891 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.92613876 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.83859250 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.62368183 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55725155 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52032584 |
| 19 | Purine metabolism_Homo sapiens_hsa00230 | 1.50626852 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49123582 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.47481808 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46064352 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45588437 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43636502 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.42284912 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41667736 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.35069366 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.33442784 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33310962 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33234682 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32286384 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29037973 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29018478 |
| 34 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.27600838 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.23948980 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23833931 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22983738 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22245163 |
| 39 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.21208508 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21165900 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19585952 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14169649 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12941577 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12799451 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11957326 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11423415 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08379453 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08194610 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.07285244 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04574822 |
| 51 | Asthma_Homo sapiens_hsa05310 | 1.03864977 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.99655538 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99241147 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96374242 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96203946 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93526567 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.92854427 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92168510 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91400993 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90815182 |
| 61 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.87233351 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.86796372 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82787968 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82175033 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82084409 |
| 66 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.81879945 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81243775 |
| 68 | Cell cycle_Homo sapiens_hsa04110 | 0.81198746 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80638886 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79180813 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77232509 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75485390 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74899814 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73892033 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72897281 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.72471858 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69404114 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67711978 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67567354 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67021005 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66794319 |
| 82 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64046649 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63969775 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63321417 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63131707 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62427999 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62416057 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61447298 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61242138 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60501369 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58412377 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56168005 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.54823559 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54284009 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54093767 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53802728 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.53333357 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53147078 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52114533 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51559469 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48480414 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48458166 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48361369 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47535433 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47419972 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46586325 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46494074 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46459608 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44646690 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44525904 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43581103 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43564434 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43537687 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43198605 |
| 115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42675941 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.42606556 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42522396 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42435606 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41930082 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41565150 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.41467274 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.41047103 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41006758 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.40477744 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39541087 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39296249 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39141129 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.38721963 |
| 129 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38497988 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38462759 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37738777 |
| 132 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36664647 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36019167 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.35918034 |
| 135 | Alcoholism_Homo sapiens_hsa05034 | 0.35714183 |
| 136 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34683168 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30802843 |
| 138 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30065633 |
| 139 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28920762 |
| 140 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28843488 |
| 141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27802258 |
| 142 | Lysine degradation_Homo sapiens_hsa00310 | 0.26459874 |
| 143 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26256208 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23762627 |
| 145 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.22879393 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21777688 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21522827 |
| 148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20324749 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15060808 |
| 150 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14573651 |

